(Q37827385)

23 August 2017

7 references

25 April 2019

20 June 2019

22 June 2019

19 September 2019

28 September 2019

20 November 2019

4 November 2020

Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm (English)

1 reference

biomedical investigative technique

23 August 2017

7 references

25 April 2019

20 June 2019

22 June 2019

19 September 2019

28 September 2019

20 November 2019

4 November 2020

1 reference

19 September 2019

1 reference

28 September 2019

1 reference

20 November 2019

health care outcome assessment

1 reference

4 November 2020

Bettina Wabbels

1

1 reference

23 August 2017

Wolfgang H Jost

series ordinal

2

1 reference

23 August 2017

Peter Roggenkämper

series ordinal

3

1 reference

23 August 2017

9 January 2011

1 reference

Journal of Neural Transmission

23 August 2017

1 June 2011

7 references

25 April 2019

20 June 2019

22 June 2019

19 September 2019

28 September 2019

20 November 2019

4 November 2020

8 references

23 August 2017

25 April 2019

20 June 2019

22 June 2019

19 September 2019

28 September 2019

20 November 2019

4 November 2020

118

1 reference

23 August 2017

6

1 reference

23 August 2017

925-943

1 reference

Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Blepharospasm: recent advances

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Effect of treatment with botulinum toxin on neurogenic blepharospasm.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Blepharospasm: a review of 264 patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Management of spasticity associated pain with botulinum toxin A.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Botulinum injection therapy for blepharospasm: a review and report of 75 patients.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Treatment of blepharospasm with botulinum toxin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

The management of blepharospasm and hemifacial spasm

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Videonystagmography to assess eyelid dynamic disorders.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Relationship between various clinical outcome assessments in patients with blepharospasm

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

A new grading system for assessing orbicularis muscle function.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104001

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-010-0546-9

Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial

21 January 2018

1 reference

12 December 2020

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm

1 reference

12 December 2020

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

1 reference

12 December 2020

Botulinum A toxin injection as a treatment for blepharospasm

1 reference

12 December 2020

The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm

1 reference

12 December 2020

Long-term treatment of blepharospasm with botulinum toxin type A

1 reference

12 December 2020

Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study

1 reference

12 December 2020

Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm

1 reference

12 December 2020

Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections

1 reference

12 December 2020

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

1 reference

12 December 2020

A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm

1 reference

12 December 2020

Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment

1 reference

12 December 2020

10.1007/S00702-010-0546-9

Identifiers

DOI

1 reference

23 August 2017

1 reference

23 August 2017

PubMed publication ID

21221669

1 reference